|
|
Volumn 7, Issue 11, 2017, Pages 1208-
|
|
Gemtuzumab Ozogamicin Makes a Comeback
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOGLYCOSIDE;
ANTIBODY CONJUGATE;
CD33 ANTIGEN;
CD33 PROTEIN, HUMAN;
GEMTUZUMAB;
MONOCLONAL ANTIBODY;
ACUTE MYELOID LEUKEMIA;
ADULT;
AGED;
ANTAGONISTS AND INHIBITORS;
DISEASE FREE SURVIVAL;
DRUG APPROVAL;
FEMALE;
HUMAN;
IMMUNOLOGY;
MALE;
MIDDLE AGED;
PATHOLOGY;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
ADULT;
AGED;
AMINOGLYCOSIDES;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DISEASE-FREE SURVIVAL;
DRUG APPROVAL;
FEMALE;
HUMANS;
IMMUNOCONJUGATES;
LEUKEMIA, MYELOID, ACUTE;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SIALIC ACID BINDING IG-LIKE LECTIN 3;
|
|
EID: 85042489932
PISSN: None
EISSN: 21598290
Source Type: Journal
DOI: 10.1158/2159-8290.CD-NB2017-132 Document Type: Article |
|
Times cited : (6)
|
|
References (0)
|